Acadia discloses $9.2M total exposure to failed Silicon Valley Bank

ACADIA PHARMACEUTICALS INC

Approximately $1M in deposit accounts at SVB for daily cash needs as of March 10, 2023.
Approximately $5.8M in restricted cash in money-market accounts as collateral for office leases and corporate charge card.
Approximately $2.4M in receivables in a lockbox account at SVB.
Company states exposure to SVB is limited; total disclosed exposure about $9.2M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.